Gene Therapy Market � Industry Analysis and Forecast (2022-2029)

Mayurikathade27 Mar, 2023Business

Gene Therapy Market size is expected to grow from US$ 6.21 Bn. in 2021 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2022 to 2029. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2029. Gene Therapy Market Overview: Global Gene Therapy market was valued at US $ 6.21 Bn. in 2021, and it is expected to reach US $ 44.51 Bn. by 2029 with a CAGR of 27.9% during the forecast period. In the last ten years, gene therapy and new treatments based on gene therapy have made significant progress. For certain disorders, clinically effective gene treatments have been produced, and many additional potential medications have been discovered, with this trend especially obvious in the field of haematological diseases. Delivery vectors, gene engineering methods, and application to chimeric antigen receptor (CAR) T cell therapy are only a few of the recent advances in gene therapy and gene therapy-based approaches.